Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Prostatome – a Novel Prostate Atlas Combining Anatomic and Disease Pathology Data Founded

By LabMedica International staff writers
Posted on 23 Jul 2014
Scientists have succeeded in fusing prostate cancer pathology data with anatomical magnetic resonance imaging (MRI) data to create the foundation of a first-of-its-kind prostate atlas for prostate cancer.

A team of scientists and clinicians, led by Anant Madabhushi, professor of biomedical engineering and director of the Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University (Cleveland, OH, USA), developed a novel framework, the anatomically constrained registration (AnCoR) scheme, and applied it to perform the fusion of initial data sets for creating the new prostate cancer (PrCa) "prostatome" atlas. More...
The methods developed in the study can now be applied with a larger sample size data set to create a more fully developed atlas, which will allow for highly accurate identification of the MRI signatures associated with PrCa extent and aggressiveness.

The atlas was constructed and validated on 80 patients from two different sites—Boston Medical Center and Beth Israel Deaconess Medical Center. The goal of the study was to integrate pathology and MRI data from multiple different PrCa patients who had undergone surgery involving complete removal of the prostate (radical prostatectomy). All patients had an MRI performed before surgery. The methods developed in this project were used to fuse the MRI scans obtained before surgery with histology data of the surgically excised specimens. This allowed for mapping of cancer extent (determined by a pathologist) in the surgically excised specimen onto the preoperative imaging, enabling construction of a novel PrCa MRI atlas that incorporates PrCa specimen information.

Prof. Madabhushi commented, “The prostatome atlas could allow for integrating imaging data from multiple different patients studies into one unified representation and thereby allow for guiding biopsies, specific treatment targeting, and also serve as an educational tool for medical students and residents.” Additionally, the AnCoR framework could allow for incorporation of complementary imaging and molecular data, thereby enabling their careful correlation for population based radio-omics.

The study, by Rusu M. et al., was described in the July, 2014, issue of the journal Medical Physics.

Related Links:
Case Western Reserve University
Center of Computational Imaging and Personalized Diagnostics




New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.